Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Provider-Administered Oncology Drugs
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Content with Policies & Guidelines Current Provider-Administered Oncology Drug Policies .
print
Print
Back
Back
Immune Globulins (immunoglobulin) (Intravenous)
Policy Number: VP-0071
Last Review Date:...
print
Print
Back
Back
Ixempra® (ixabepilone) (Intravenous)
Policy Number: VP-0072
Last Review Date:...
print
Print
Back
Back
Aloxi® (palonosetron) (Intravenous)
Policy Number: VP-008
Last Review Date:...
print
Print
Back
Back
Nplate™ (romiplostim) (Subcutaneous)
Policy Number: VP-0089
Last Review Date:...
print
Print
Back
Back
Kadcyla® (ado-trastuzumab emtansine) (Intravenous)
Policy Number: VP-0092
Last...
print
Print
Back
Back
Perjeta® (pertuzumab) (Intravenous)
Policy Number: VP-0096
Last Review Date:...
print
Print
Back
Back
Provenge® (sipuleucel-T) (Intravenous)
Policy Number: VP-0100
Last Review Date:...
print
Print
Back
Back
Rituximab: Rituxan®, Truxima®, Ruxience®, Riabni™ (Intravenous)
Policy Number: VP-0109...
print
Print
Back
Back
Bendamustine: Treanda®; Bendeka®; Belrapzo®; Vivimusta™; Bendamustine Ψ (Intravenous)...